AIMC Topic: Endometrial Neoplasms

Clear Filters Showing 1 to 10 of 107 articles

Ultrasound-based machine learning model to predict the risk of endometrial cancer among postmenopausal women.

BMC medical imaging
BACKGROUND: Current ultrasound-based screening for endometrial cancer (EC) primarily relies on endometrial thickness (ET) and morphological evaluation, which suffer from low specificity and high interobserver variability. This study aimed to develop ...

Exploration of shared pathogenic factors and causative genes in early-stage endometrial cancer and osteoarthritis.

Scientific reports
Osteoarthritis (OA) has been implicated in the development and progression of early-stage endometrial cancer (EC), suggesting shared pathogenic factors between the two diseases. This study aimed to investigate the causal relationship between OA and E...

A radiogenomics study on F-FDG PET/CT in endometrial cancer by a novel deep learning segmentation algorithm.

BMC cancer
OBJECTIVE: To create an automated PET/CT segmentation method and radiomics model to forecast Mismatch repair (MMR) and TP53 gene expression in endometrial cancer patients, and to examine the effect of gene expression variability on image texture feat...

Multi-omics identifies OSM-OSMR as a key receptor-ligand in the tumor environment of endometrial adenocarcinoma.

International immunopharmacology
Endometrial adenocarcinoma carries a bleak prognosis, and the molecular markers that evaluate the progression of endometrial adenocarcinoma to advanced stages remain uncertain. Cell-cell communication plays a crucial role in the tumor microenvironmen...

Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence.

JCO precision oncology
PURPOSE: Endometrial cancer (EC) is the most common gynecologic cancer in the United States with rising incidence and mortality. Despite optimal treatment, 15%-20% of all patients will recur. To better select patients for adjuvant therapy, it is impo...

Diagnosis Test Accuracy of Artificial Intelligence for Endometrial Cancer: Systematic Review and Meta-Analysis.

Journal of medical Internet research
BACKGROUND: Endometrial cancer is one of the most common gynecological tumors, and early screening and diagnosis are crucial for its treatment. Research on the application of artificial intelligence (AI) in the diagnosis of endometrial cancer is incr...

ECP-GAN: Generating Endometrial Cancer Pathology Images and Segmentation Labels via Two-Stage Generative Adversarial Networks.

Annals of surgical oncology
BACKGROUND: Endometrial cancer is one of the most common tumors of the female reproductive system and ranks third in the world list of gynecological malignancies that cause death. However, due to the privacy and complexity of pathology images, it is ...

OnmiMHC: a machine learning solution for UCEC tumor vaccine development through enhanced peptide-MHC binding prediction.

Frontiers in immunology
The key roles of Major Histocompatibility Complex (MHC) Class I and II molecules in the immune system are well established. This study aims to develop a novel machine learning framework for predicting antigen peptide presentation by MHC Class I and I...

Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer.

Cancer immunology, immunotherapy : CII
With the incorporation of immune checkpoint inhibitors into the treatment of endometrial cancer (EC), a deeper understanding of the tumor immune microenvironment is critical. Tertiary lymphoid structures (TLSs) are considered favorable prognostic fac...

Interpretable multi-stage attention network to predict cancer subtype, microsatellite instability, TP53 mutation and TMB of endometrial and colorectal cancer.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society
Mismatch repair deficiency (dMMR), also known as high-grade microsatellite instability (MSI-H), is a well-established biomarker for predicting the immunotherapy response in endometrial cancer (EC) and colorectal cancer (CRC). Tumor mutational burden ...